DEB-TACE achieved superior therapeutic effects compared to cTACE because of its ability to induce more comprehensive embolization, unlike cTACE which uses lipiodol and can only partially embolize tumor blood vessels and supply arteries, activating the hypoxia/VEGF signaling pathway.36 The gene discussed is VEGFA; the disease is neoplasm.